RCM Technologies, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by RCM Technologies, Inc. (RCMT) on May 6, 2025. The report discloses a specific corporate governance event regarding executive compensation approved by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a non-financial executive compensation event.
Material Changes
On May 6, 2025, the Company approved the grant of up to 2,904 performance stock units (PSUs) to Michael Saks, Division President of Health Care Services, under the 2014 Omnibus Equity Compensation Plan.
- Performance Period: December 29, 2024, to January 3, 2026.
- Vesting Condition: Achievement of established operating income levels.
- Change in Control: Grants are subject to accelerated vesting in the event of a Change in Control.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of general risks and contingencies beyond the standard terms of the equity grant.
Key Facts for Investor Verification
- Verify the specific operating income targets required to vest the 2,904 PSUs granted to Michael Saks.
- Confirm the total number of shares available under the 2014 Omnibus Equity Compensation Plan post-grant.
- Review the definition of "Change in Control" within the 2014 Plan to understand accelerated vesting triggers.